<DOC>
	<DOCNO>NCT02000830</DOCNO>
	<brief_summary>The objective follow study evaluate long-term effect stannsoporfin ( Stanate ) health , growth , development patient receive single dose stannsoporfin PT use treat hyperbilirubinemia compare patient control ( placebo plus PT ) group clinical trial 64,185-204 .</brief_summary>
	<brief_title>Follow Study Patients Having Participated Clinical Trial 64,185-204</brief_title>
	<detailed_description>Outcomes base follow variable : Reported AEs SAEs Hearing assessment Developmental assessment</detailed_description>
	<mesh_term>Tin mesoporphyrin</mesh_term>
	<criteria>Patients receive IMP ( stannsoporfin placebo ) clinical trial 64,185204 Parents guardian give write informed consent participate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>52 Months</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>stannsoporfin</keyword>
</DOC>